Market Research Logo

Quanterix Corp - Product Pipeline Analysis, 2017 Update

Summary

Quanterix Corp (Quanterix) is a medical equipment provider that offers proteins measurement solutions. The company’s products comprise simoa HD1 analyzer, assay kits and consumables. It provides assay kits such as C-peptide simoa assay kit, homebrew assay kit, homebrew bead and SBG kit, PSA simoa assay kit, tau simoa assay kit and TNF-a simoa assay kit. Quanterix's products are used in life sciences research, oncology, neurology, inflammatory disease and infectious disease areas. The company markets its products across the US. Quanterix is headquartered in Lexington, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Quanterix Corp
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Quanterix Corp Company Overview
Quanterix Corp Company Snapshot
Quanterix Corp Pipeline Products and Ongoing Clinical Trials Overview
Quanterix Corp – Pipeline Analysis Overview
Quanterix Corp - Key Facts
Quanterix Corp - Major Products and Services
Quanterix Corp Pipeline Products by Development Stage
Quanterix Corp Pipeline Products Overview
AccuPSA Test
AccuPSA Test Product Overview
Antigen Detection Assay - Tuberculosis
Antigen Detection Assay - Tuberculosis Product Overview
Diagnostic Assay - Alzheimer’s Disease
Diagnostic Assay - Alzheimer’s Disease Product Overview
Digital ELISA - Crohn’s Disease
Digital ELISA - Crohn’s Disease Product Overview
Digital ELISA Assay - C. Difficile
Digital ELISA Assay - C. Difficile Product Overview
POC Device - Neurological Injuries
POC Device - Neurological Injuries Product Overview
Simoa 3.0
Simoa 3.0 Product Overview
Simoa 4.0
Simoa 4.0 Product Overview
Simoa 5.0
Simoa 5.0 Product Overview
SiMoA HD-1 Analyzer - Botulinum Toxin Assay
SiMoA HD-1 Analyzer - Botulinum Toxin Assay Product Overview
SiMoA HD-1 Analyzer - Prostate Cancer Assay
SiMoA HD-1 Analyzer - Prostate Cancer Assay Product Overview
Ultra-sensitive Assay - a-synuclein
Ultra-sensitive Assay - a-synuclein Product Overview
Ultra-sensitive Assay - p-Tau
Ultra-sensitive Assay - p-Tau Product Overview
Quanterix Corp - Key Competitors
Quanterix Corp - Key Employees
Quanterix Corp - Locations And Subsidiaries
Head Office
Recent Developments
Quanterix Corp, Recent Developments
Jul 18, 2017: Quanterix, Partners Develop PCR-free miRNA Detection Method for Liver Toxicity Testing
Jul 18, 2017: Quanterix Boosts Investments in its Accelerator Lab to Support Rapid Growth of Simoa Technology
Jul 06, 2017: Single Molecule Microrna Technology Proves Useful for Liver Toxicity Detection
May 17, 2017: Quanterix Launches the First Comprehensive Multiplex Panel to Study Traumatic Brain Injury Severity
May 09, 2017: Smithers Avanza Adds Quanterix’ Simoa Technology to Bioanalytical Laboratory
Jan 05, 2017: Quanterix to Present at The 35th Annual J.P. Morgan Healthcare Conference
Jun 15, 2016: Frontage Laboratories Announces Partnership with Quanterix and Validation of Simoa HD-1 Analyzer and Software to Support Biomarker Analysis
Apr 18, 2016: Quanterix Opens Call for Proposals for Second Annual Accelerator Grant Program Focused on Oncology and Liquid Tumor Biopsy Technology
Mar 03, 2016: Quanterix’s Single Molecule Array Technology Unlocks New Biomarker Fueling Advancements in Neurological Research
Feb 10, 2016: Quanterix Names Frontage Laboratories as a Preferred Partner in Biomarker Assay Development and Testing Services in the Regulated Space
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Quanterix Corp Pipeline Products and Ongoing Clinical Trials Overview
Quanterix Corp Pipeline Products by Equipment Type
Quanterix Corp Pipeline Products by Indication
Quanterix Corp, Key Facts
Quanterix Corp, Major Products and Services
Quanterix Corp Number of Pipeline Products by Development Stage
Quanterix Corp Pipeline Products Summary by Development Stage
AccuPSA Test - Product Status
AccuPSA Test - Product Description
Antigen Detection Assay - Tuberculosis - Product Status
Antigen Detection Assay - Tuberculosis - Product Description
Diagnostic Assay - Alzheimer’s Disease - Product Status
Diagnostic Assay - Alzheimer’s Disease - Product Description
Digital ELISA - Crohn’s Disease - Product Status
Digital ELISA - Crohn’s Disease - Product Description
Digital ELISA Assay - C. Difficile - Product Status
Digital ELISA Assay - C. Difficile - Product Description
POC Device - Neurological Injuries - Product Status
POC Device - Neurological Injuries - Product Description
Simoa 3.0 - Product Status
Simoa 3.0 - Product Description
Simoa 4.0 - Product Status
Simoa 4.0 - Product Description
Simoa 5.0 - Product Status
Simoa 5.0 - Product Description
SiMoA HD-1 Analyzer - Botulinum Toxin Assay - Product Status
SiMoA HD-1 Analyzer - Botulinum Toxin Assay - Product Description
SiMoA HD-1 Analyzer - Prostate Cancer Assay - Product Status
SiMoA HD-1 Analyzer - Prostate Cancer Assay - Product Description
Ultra-sensitive Assay - a-synuclein - Product Status
Ultra-sensitive Assay - a-synuclein - Product Description
Ultra-sensitive Assay - p-Tau - Product Status
Ultra-sensitive Assay - p-Tau - Product Description
Quanterix Corp, Key Employees
Glossary
List of Figures
Quanterix Corp Pipeline Products by Equipment Type
Quanterix Corp Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report